Anaergia purchases two bioenergy facilities in the US
The Transaction advances Anaergia’s strategy to concentrate its portfolio around profitable growth opportunities and eliminate the negative earnings associated with non-core assets, as CBF has not been operating and RIBF has been operating below its expected capacity.
Under the Transaction, Anaergia sold CBF and deconsolidated its interest in RIBF. Approximately C$20 million of project-level debt will be removed from Anaergia’s balance sheet. In exchange, Anaergia has received approximately C$9 million of equity in the buyer, a privately held company. The Transaction is expected to result in a non-cash gain on sale.
Category: Fuels









